Your session is about to expire
← Back to Search
Dietary Supplement
Oxalate-Controlled Diets for Kidney Stones
N/A
Recruiting
Led By Tanecia Mitchell, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Men and women between the ages of 18 and 60 years old
Patients with CaOx KS: Recent stone composition > 50% CaOx; no uric acid, struvite, or carbonate apatite stone content
Must not have
Active illness including COVID-19, flu, common cold, fever, diarrhea, urinary tract infections, or other infections 14 days before the study and throughout the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up days 3-4 and 13-14
Awards & highlights
No Placebo-Only Group
Summary
This trial is investigating how oxalate affects kidney stones and immunity. It will last for 3 weeks, during which participants will eat a controlled diet and provide blood and urine samples.
Who is the study for?
This trial is for adults aged 18-60 with a BMI of 20-30, not using tobacco or pregnant. It includes healthy individuals and those with calcium oxalate kidney stones who are willing to follow specific diets provided by the study and avoid vigorous exercise. Participants must be able to give informed consent, have normal blood tests, and collect accurate urine samples.
What is being tested?
The study aims to understand how dietary oxalate affects kidney stone formation and immune responses. For about three weeks, participants will consume either a low or high oxalate diet while providing blood and urine samples for analysis.
What are the potential side effects?
While the trial itself does not involve medication that typically has side effects, changes in diet can cause digestive discomfort such as bloating or constipation. The impact on each individual may vary based on their body's response to the dietary changes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 60 years old.
Select...
My recent kidney stone was mostly calcium oxalate, without uric acid, struvite, or carbonate apatite.
Select...
I have no history of kidney stones or other significant health issues.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have not had any infections like COVID-19 or the flu in the last 14 days.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ days 3-4 and 13-14
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~days 3-4 and 13-14
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Nanocystalluria
Change in Urinary Oxalate
Monocyte Cellular Bioenergetics and Mitochondrial Function
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Healthy ParticipantsExperimental Treatment2 Interventions
Healthy participants will randomly receive either high (250mg) or low (40mg) oxalate diet for for four days, a ten day "washout" period on a self-selected diet, and finally the opposite diet from the first for the last four days.
Group II: Calcium Oxalate Kidney StoneExperimental Treatment2 Interventions
Calcium oxalate kidney stone participants will randomly receive either high (250mg) or low (40mg) oxalate diet for for four days, a ten day "washout" period on a self-selected diet, and finally the opposite diet from the first for the last four days.
Find a Location
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,337,365 Total Patients Enrolled
7 Trials studying Kidney Stones
570 Patients Enrolled for Kidney Stones
University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,285 Total Patients Enrolled
13 Trials studying Kidney Stones
653 Patients Enrolled for Kidney Stones
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,172,535 Total Patients Enrolled
2 Trials studying Kidney Stones
40 Patients Enrolled for Kidney Stones
Tanecia Mitchell, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
3 Previous Clinical Trials
190 Total Patients Enrolled
3 Trials studying Kidney Stones
190 Patients Enrolled for Kidney Stones
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 60 years old.You need to have normal results for certain blood and urine tests taken after fasting.I can provide two accurate 24-hour urine samples matching my gender's creatinine to weight ratio.I have taken medications or supplements recently and do not have conditions affecting oxalate processing.I've been on a stable dose of KS prevention medication for 8 weeks and haven't taken allopurinol for 2 weeks.I have not had any infections like COVID-19 or the flu in the last 14 days.My recent kidney stone was mostly calcium oxalate, without uric acid, struvite, or carbonate apatite.I do not meet all the required conditions or my doctor advised against it.You do not use tobacco, and you are not pregnant or breastfeeding.Your body mass index (BMI) is between 20 and 30.Your body mass index (BMI) is above 30 or below 20.I have no history of kidney stones or other significant health issues.Your 24-hour urine collection was not done correctly.Your blood and urine tests show abnormal results when you haven't eaten for a while.
Research Study Groups:
This trial has the following groups:- Group 1: Calcium Oxalate Kidney Stone
- Group 2: Healthy Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.